Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny De Looze

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Elife|October 7, 2015
Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirsEva Malatinkova, Ward De Spiegelaere, Pawel Bonczkowski, et al.
Journal of Clinical Gastroenterology|April 9, 2015
World gastroenterology organisation global guidelines: dysphagia--global guidelines and cascades update September 2014Juan-R Malagelada, Franco Bazzoli, Guy Boeckxstaens, et al.
Endoscopy International Open|March 3, 2020
Clinical implications of decision making in colorectal polypectomy: an international survey of Western endoscopists suggests priorities for changeDavid J Tate, Lobke Desomer, Steven J Heitman, et al.
Eclinicalmedicine|April 30, 2024
Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trialArnout Bruggeman, Charysse Vandendriessche, Hannelore Hamerlinck, et al.
Gut|January 8, 2024
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trialLisse Decraecker, Danny De Looze, David P Hirsch, et al.
Cell Host & Microbe|September 1, 2019
HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse ReservoirsMarie-Angélique De Scheerder, Bram Vrancken, Simon Dellicour, et al.
Frontiers in Pediatrics|February 22, 2021
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes MellitusConstance Carels, Lucas Wauters, An Outtier, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2022
Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trialsJeroen Geldof, Nusrat Iqbal, Jean-Frédéric LeBlanc, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2024
Perianal Fistulizing Crohn's Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized CareLuke N Hanna, Sulak Anandabaskaran, Nusrat Iqbal, et al.
The Lancet Regional Health. Europe|October 25, 2021
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide surveySimon Mark Dahl Baunwall, Elisabeth M Terveer, Jens Frederik Dahlerup, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Elife|October 7, 2015
Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirsEva Malatinkova, Ward De Spiegelaere, Pawel Bonczkowski, et al.
Journal of Clinical Gastroenterology|April 9, 2015
World gastroenterology organisation global guidelines: dysphagia--global guidelines and cascades update September 2014Juan-R Malagelada, Franco Bazzoli, Guy Boeckxstaens, et al.
Endoscopy International Open|March 3, 2020
Clinical implications of decision making in colorectal polypectomy: an international survey of Western endoscopists suggests priorities for changeDavid J Tate, Lobke Desomer, Steven J Heitman, et al.
Eclinicalmedicine|April 30, 2024
Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trialArnout Bruggeman, Charysse Vandendriessche, Hannelore Hamerlinck, et al.
Gut|January 8, 2024
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trialLisse Decraecker, Danny De Looze, David P Hirsch, et al.
Cell Host & Microbe|September 1, 2019
HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse ReservoirsMarie-Angélique De Scheerder, Bram Vrancken, Simon Dellicour, et al.
Frontiers in Pediatrics|February 22, 2021
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes MellitusConstance Carels, Lucas Wauters, An Outtier, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2022
Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trialsJeroen Geldof, Nusrat Iqbal, Jean-Frédéric LeBlanc, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2024
Perianal Fistulizing Crohn's Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized CareLuke N Hanna, Sulak Anandabaskaran, Nusrat Iqbal, et al.
The Lancet Regional Health. Europe|October 25, 2021
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide surveySimon Mark Dahl Baunwall, Elisabeth M Terveer, Jens Frederik Dahlerup, et al.
Pageof 3